|
Volumn 24, Issue 17, 2014, Pages 4247-4249
|
A new series of HAPs as anti-HBV agents targeting at capsid assembly
|
Author keywords
Anti HBV; Capsid; HAPs; SEC
|
Indexed keywords
ANTIVIRUS AGENT;
CYTOTOXIC AGENT;
HETEROARYLDIHYDROPYRIMIDINE;
LAMIVUDINE;
UNCLASSIFIED DRUG;
PYRIMIDINE DERIVATIVE;
VIRUS DNA;
ANTIVIRAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DNA REPLICATION;
DRUG DESIGN;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
VIRUS CAPSID;
VIRUS INHIBITION;
CELL SURVIVAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG EFFECTS;
GROWTH, DEVELOPMENT AND AGING;
HEPG2 CELL LINE;
METABOLISM;
MICROBIAL SENSITIVITY TEST;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
VIRUS REPLICATION;
HEPATITIS B VIRUS;
MIRIDAE;
ANTIVIRAL AGENTS;
CAPSID;
CELL SURVIVAL;
DNA, VIRAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEP G2 CELLS;
HEPATITIS B VIRUS;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
PYRIMIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRUS REPLICATION;
|
EID: 84906934387
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2014.07.032 Document Type: Article |
Times cited : (18)
|
References (10)
|